EMAIL THIS PAGE TO A FRIEND

Antimicrobial agents and chemotherapy

Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agents.


PMID 21115793

Abstract

Efforts to develop novel, interferon-sparing therapies for treatment of chronic hepatitis C (HCV) infection are contingent on the ability of combination therapies consisting of direct antiviral inhibitors to achieve a sustained virologic response. This work demonstrates a proof of concept that coadministration of the nucleoside analogue MK-0608 with the protease inhibitor MK-7009, both of which produced robust viral load declines as monotherapy, to an HCV-infected chimpanzee can achieve a cure of infection.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T0642
Tubercidin, from Streptomyces tubercidicus, ~95%
C11H14N4O4